|
 On October 18, 2004, Pfizer admitted that two small clinical trials showed heart bypass surgery patients taking Bextra had a higher risk of stroke and heart attack. Bextra is in the same class of drugs as Celebrex and the recently recalled Vioxx (COX-2 enzyme inhibitors - classified Non-Steroidal Anti-Inflammatory Medications {NSAIDs}).
On November 11, 2004, University of Pennsylvania researchers told the American Heart Association that a recent clinical trial revealed that patients taking Bextra had more than twice the incidence of heart attack and stroke than nonusers. University of Pennsylvania pharmacologist Dr. Garret FitzGerald claims "The magnitude of [cardiac problems] with Bextra is even higher than what we saw in Vioxx." Bextra's risk appeared to pose a slightly higher risk than Vioxx for heart attack and stroke.
On April 4, 2005, The FDA forced Pfizer pull it's blockbuster painkiller Bextra of the market due to cardiac concerns and serious skin conditions (some fatal). The FDA also forced numerous other popular prescription competitors like Celebrex and other NSAIDs to carry tougher new warnings that they, too, may increase the risk of heart attacks and strokes. This is a continuing Saga from last September 2004, when Merck & Company voluntarily pulled its pain reliever Vioxx from the market after studies showed increased risks of heart attacks and strokes.
Ricci~Leopold is available to associate with you in evaluating and prosecuting Bextra claims involving individuals who, while taking Bextra suffered a heart attack, stroke or other severe cardiac injury, including death.
If you believe that you or a loved one has been adversely affected by Bextra, please fill out an evaluation form. Provide as much information as possible to speed the processing of your inquiry.
Ricci~Leopold is here to assist you with any communication needs that will help get this important, timely information to the general public.
Please call Meg Sadaka at (800)699-1914 with any questions you may have.
Related information on - Vioxx - Celebrex.
|
